Court Place Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Court Place Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,461	Closed	-$211K	–	185
2019 Q1	$211K	Sell	13,461 -140	-1%	-$2.47K	0.09%	170
2018 Q4	$210K	Buy	+13,601	New	+$279K	0.1%	156
2018 Q3	–	Sell	-9,034	Closed	-$220K	–	181
2018 Q2	$220K	Buy	+9,034	New	+$184K	0.09%	160
2017 Q4	–	Sell	-14,455	Closed	-$254K	–	173
2017 Q3	$254K	Buy	14,455 +2,688	+23%	+$60.5K	0.11%	145
2017 Q2	$391K	Buy	11,767 +2,435	+26%	+$75.4K	0.19%	110
2017 Q1	$299K	Buy	9,332 +875	+10%	+$29.9K	0.15%	121
2016 Q4	$307K	Buy	+8,457	New	+$338K	0.16%	115

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Court Place Advisors's TEVA Position: Q2 2019 in Review

Court Place Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 13,461 shares — an estimated $211K sold.

Court Place Advisors first reported a position in TEVA in Q4 2016 and held it in 7 quarters. The position peaked at $391K in Q2 2017. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Court Place Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
Court Place Advisors sold 13,461 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $211K.
Court Place Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 7 quarters.
Court Place Advisors's Teva Pharmaceutical Industries Limited position peaked at $391K in Q2 2017.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Court Place Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.